The Latest Analyst Ratings for Alimera Sciences
Portfolio Pulse from Benzinga Insights
Alimera Sciences (NASDAQ:ALIM) has received four bullish analyst ratings in the last quarter, with an average price target of $5.75, indicating potential upside from the current price of $3.41. This average price target has decreased by 14.81% from the previous average of $6.75.
August 14, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alimera Sciences has received positive analyst ratings, which could potentially drive the stock price up in the short term.
Analyst ratings often influence investor sentiment and can impact stock prices. The bullish ratings for Alimera Sciences indicate a positive outlook for the stock, which could potentially lead to an increase in its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100